J. Llevadot

发表

Constitutive Human Telomerase Reverse Transcriptase Expression Enhances Regenerative Properties of Endothelial Progenitor Cells

J. Isner, T. Asahara, Douglas Losordo, 2002, Circulation.

Bolus fibrinolytic therapy in acute myocardial infarction.

E. Antman, R. Giugliano, J. Llevadot, 2001, JAMA.

Pharmacology and clinical trial results of lanoteplase in acute myocardial infarction

R. Giugliano, J. Llevadot, 2000, Expert opinion on investigational drugs.

[Effects of statins on angiogenesis and vasculogenesis].

T. Asahara, J. Llevadot, 2002, Revista espanola de cardiologia.

Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).

E. Antman, C. Cannon, S. Murphy, 2000, The American journal of cardiology.

[Evolution of systolic function and myocardial perfusion, evaluated by gated-SPECT, in the first year after acute myocardial infarction].

J. Soler‐Soler, J. Candell‐Riera, J. Castell‐Conesa, 2003, Revista espanola de cardiologia.

Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

N. Rifai, A. Klibanski, D. Hayden, 2000, Annals of internal medicine.

A Practical Approach to the Diagnosis and Management of Thrombocytopenia Associated with Glycoprotein IIb/IIIa Receptor Inhibitors

R. Giugliano, S. Coulter, J. Llevadot, 2000, Journal of Thrombosis and Thrombolysis.

L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism.

L. Agulló, J. Soler‐Soler, J. Inserte, 1999, The American journal of physiology.

Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency

N. Rifai, A. Klibanski, D. Hayden, 2000, Annals of Internal Medicine.

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

J. Isner, K. Walsh, Y. Kureishi, 2001, The Journal of clinical investigation.

Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.

E. Antman, R. Giugliano, N. Rifai, 2000, Clinica chimica acta; international journal of clinical chemistry.

Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction.

E. Antman, E. Braunwald, T. Henry, 2001, European heart journal.

Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II.

E. Antman, E. Braunwald, A. Charlesworth, 2001, European heart journal.

Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT

L. Armadans, J. Soler‐Soler, J. Candell‐Riera, 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.

N. Rifai, A. Klibanski, D. Hayden, 2001, The Journal of clinical endocrinology and metabolism.

l-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism.

L. Agulló, J. Soler‐Soler, J. Inserte, 1999, American journal of physiology. Heart and circulatory physiology.